Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check7 days agoChange DetectedThe page history shows Revision: v3.3.3 added and HHS Vulnerability Disclosure and Revision: v3.3.2 removed. These are administrative/site-structure updates that do not affect trial data or content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.3.2 to the page history. Removed the funding lapse notice and the previous Revision: v3.2.0.SummaryDifference0.3%

- Check57 days agoChange DetectedDifference0.0%

- Check86 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference8%

- Check93 days agoChange DetectedReleased a new version: v3.1.0, replacing the old v3.0.2. This is a core content update reflecting an updated software version.SummaryDifference0.2%

- Check108 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.5%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.